Gene · 445
NIH grants1,983
NIH grants whose papers are about the gene, through NIH's grant-paper links.
241 to 260 of 1,983
Download this page as JSON| Grant | Title | ASS1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL149762 | Formyl peptide receptor activation induces vascular plasticity and remodeling inhypertension | 1 | 2025 |
| R01HL160661 | Metabolic regulation of hypercapnic chronic obstructive pulmonary disease (COPD)-driven skeletal muscle dysfunction | 1 | 2025 |
| R01MH098062 | Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project | 1 | 2025 |
| R01MH130666 | Toward Connectomic Deep Brain Stimulation in Obsessive Compulsive Disorder | 1 | 2025 |
| R01NS050915 | Primary Progressive Aphasia: Cognition, Anatomy and Progression | 1 | 2025 |
| R01NS065244 | Mechanisms of Prion Protein Toxicity | 1 | 2025 |
| R01NS107733 | Neuronal Mechanisms of Metabolic and Genetic Defects of the Peroxisome | 1 | 2025 |
| R01NS118929 | Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2 | 1 | 2025 |
| R01NS119275 | Using NAD+ precursor for treatment of global cerebral ischemia | 1 | 2025 |
| R01NS122904 | Investigating the Thalamic Regulation of Neuro-Glio-Vascular Restoration Underlying Acute Coma Recovery with Multi-Modal fMRI in a Brainstem Coma Rodent Model | 1 | 2025 |
| R01NS126851 | Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy | 1 | 2025 |
| R01NS129123 | Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma. | 1 | 2025 |
| R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 1 | 2025 |
| R24AA025017 | Clinical Resource for Alcoholic Hepatitis Inestigation | 1 | 2025 |
| R24GM137786 | IDeA National Resource for Quantitative Proteomics | 1 | 2025 |
| R25GM143298 | The 'Career MODE' Program: Careers through Mentoring and training in Omics and Data for Early-stage investigators | 1 | 2025 |
| R33AG061456 | Translational Geroscience Network | 1 | 2025 |
| R35CA197583 | Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer | 1 | 2025 |
| R35CA197623 | Targeting intratumor heterogeneity in breast cancer | 1 | 2025 |
| R35CA232105 | Precision microRNA medicine in cancer | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/grants?page=13